HCMV glycoprotein B nucleoside-modified mRNA vaccine elicits antibody responses with greater durability and breadth than MF59-adjuvanted gB protein immunization
Published in 2019 by
Cody S. Nelson,
Jennifer A. Jenks,
Norbert Pardi,
Matthew Goodwin,
Hunter Roark,
Whitney Edwards,
Jason S. McLellan 
,
Justin Pollara,
Drew Weissman,
Sallie R. Permar
,
Justin Pollara,
Drew Weissman,
Sallie R. Permar
